Archive 2023-2024 Drug review data information

May 15, 2024 affordability review reports

• Ozempic Affordability Review updated
  
• Trulicity Affordability Review updated

Feb. 21, 2024 affordability review reports

• Ozempic Affordability Review
  
• Trulicity Affordability Review

Jan. 26, 2024 affordability review reports

• Tresiba & Tresiba FlexTouch Affordability Review - version 2
  
• Humulin R U-500 KwikPen Affordability Review - version 2
  

Jan. 10, 2024 affordability review reports

• Tresiba & Tresiba FlexTouch Affordability Review - version 1
• Humulin R U-500 KwikPen Affordability Review - version 1

Prescription drug and insulin list for affordability review (approved by the board on Dec. 13, 2023)

• Oregon PDAB prescription drug and insulin list for affordability review (PDF)

Dec. 13, 2023 board revised subset lists

• Prescription drugs
  
• Insulin
  
• Data calculations and methodology (PDF)

On November 15, 2023 the board selected subsets for prescription drugs and insulin pursuant to OAR-925-200-0010

• Oregon PDAB drug and insulin subset lists (PDF)

Data for board review on November 15, 2023

• Revised prescription drug subset list (Excel)r/>
• Insulin data analysis 2021 through 2022 (Excel)

On October 18, 2023, the board selected a subset list of prescription drugs pursuant to OAR 925-200-0010

• Prescription drug subset list (PDF)
• Board criteria used to create the prescription drug subset list (PDF)
  
• Video of the board affordability review discussion and vote on the subset list (mp4)

Data for board review on October 18, 2023

• PDAB working drug list (Excel)
  Data source and definitions: PDAB working drug list (PDF)
  
• DPT manufacturer data annual price increase report 2022 (Excel)
  Data source and definitions: DPT manufacturer data annual price increase report 2022 (PDF)
• DPT manufacturer data new specialty drugs report 2022 (Excel)
  Data source and definitions: DPT Manufacturer data new specialty drugs report 2022 (PDF)
• Insulin data analysis 2021 through 2022 (Excel)
  Data source and definitions: Insulin data analysis 2021 through 2022 (PDF)

Data for board review on September 20, 2023

• DPT manufacturer data annual price increase report 2022 (Excel)
• DPT manufacturer data new specialty drugs report 2022(Excel)
• Insulin data analysis 2021 through 2022(Excel)
• Top 25 lists DPT carrier data 2022 (Excel)